(01-29-2021 09:20 AM)Tiger1983 Wrote:  1. J&J’s single shot vaccine is 66% effective per study.

2. Generally safe and well tolerated

3. J&J will seek approval early next month.

4. J&J can ship millions of doses right away and produce a billion shots by the end of the year.

5. It uses a modified virus behind the common cold to deliver a gene from the coronavirus. The gene instructs human cells to make a protein resembling the spike protein found on the the coronavirus’s surface.

https://www.wsj.com/articles/j-j-covid-1...01?mod=mhp

Thanks, add a couple of things -

This is the J&J single shot -- they also have a two dose study on going.

The single shot was about 55% effective in the South Africa portion of the study. Because of the variant there?

50 plus days post vaccination 100% had produced antibodies. Prior to 50 days less than 100%.